Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.6461
-0.0138 (-2.09%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $18.09 million as of August 7, 2026. Its market cap has decreased by -59.59% in one year.
Market Cap
18.09M
Enterprise Value
4.70M
1-Year Change
-59.59%
Ranking
Category
Stock Price
$0.65
ChartMarket Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $18.09M, a decrease of -85.26%. That is a compound annual growth rate of -25.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 18.09M | -64.68% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 20.21M |
| Werewolf Therapeutics | 20.15M |
| Daré Bioscience | 20.07M |
| Atossa Therapeutics | 19.89M |
| Polyrizon | 19.09M |
| Tvardi Therapeutics | 19.04M |
| NewcelX | 18.57M |
| NeuroSense Therapeutics | 18.38M |